lactic acid has been researched along with betadex in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (4.65) | 18.2507 |
| 2000's | 11 (25.58) | 29.6817 |
| 2010's | 29 (67.44) | 24.3611 |
| 2020's | 1 (2.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cattaneo, MV; Luong, JH | 1 |
| Langer, R; Najjar, R; Shastri, VP; Sinisterra, RD | 1 |
| Kang, F; Singh, J | 1 |
| Cheruvu, NP; Dhanda, DS; Kompella, UB; Koushik, K | 1 |
| De Rosa, G; Immacolata La Rotonda, M; Larobina, D; Musto, P; Quaglia, F; Ungaro, F | 1 |
| Anderson, JM; Blanco, E; Gao, J; Stowe, NT; Weinberg, BD | 1 |
| Hauser, PC; Kubán, P; Law, WS; Li, SF; Zhao, JH | 1 |
| Castellanos, IJ; Flores, G; Griebenow, K | 1 |
| Fan, YG; Gao, H; Ma, JB; Yang, YW | 1 |
| Bae, JH; Kim, JJ; Kwon, MJ; Lee, ES; Na, K | 1 |
| Desai, KG; Mallery, SR; Schwendeman, SP | 1 |
| Du, G; Hao, A; Shen, J; Sun, H; Zhang, H | 1 |
| d'Emmanuele di Villa Bianca, R; Giovino, C; La Rotonda, MI; Miro, A; Quaglia, F; Sorrentino, R; Ungaro, F | 1 |
| Chan, SY; Fathi-Azarbayjani, A | 1 |
| Davaran, S; Mooguee, M; Omidi, Y | 1 |
| Barberis, A; Carson, DA; Chan, M; Corr, M; Cottam, HB; Crain, B; Hayashi, T; Leoni, L; Maj, R | 1 |
| Allard, E; Benoit, JP; Bilensoy, E; Calış, S; Cırpanlı, Y; Lemaire, L; Passirani, C | 1 |
| Bilensoy, E; Calis, S; Cirpanli, Y; Dogan, AL | 1 |
| Hermans, K; Ludwig, A; Weyenberg, W | 1 |
| Ahsan, F; Davis, M; Gupta, V; Hope-Weeks, LJ | 1 |
| Chauhan, SC; Dobberpuhl, MR; Jaggi, M; Maher, DM; Yallapu, MM | 1 |
| Almenar, E; Auras, R; Joo, MJ; Merkel, C | 1 |
| Calpena, AC; Egea, MA; Espina, M; García, ML; Vega, E | 1 |
| Griebenow, K; Montalvo-Ortiz, BL; Sosa, B | 1 |
| Amiel, C; El Fagui, A | 1 |
| Goepferich, A; Golas, MM; Miller, T; Sander, B; Uezguen, S; van Colen, G; Weigandt, M | 1 |
| Du, D; Jiang, CL; Li, MH; Liu, MF; Meng, Q; Peng, HS; Sun, SL; Tao, HQ; Wang, YM; Yang, HC; Yang, LZ; Ye, W; Yu, H; Zhu, DL | 1 |
| Feng, Q; Guo, X; She, Z; Tan, R; Wang, M | 1 |
| Calpena, AC; Egea, MA; Espina, M; García, ML; Garduño-Ramírez, ML; Sánchez, E; Vega, E | 1 |
| Chan, HK; Chan, JG; D'Sa, D; Foley, M; Wong, J | 1 |
| Huang, Y; Liu, Z; Niu, Z; Qiao, J; Tian, Y; Wu, M | 1 |
| Kang, Y; Liu, H; Liu, S; Wang, M; Xu, Z; Yang, C | 1 |
| Byun, Y; Han, JH; Kim, YT; Rodriguez, K | 1 |
| Ganem, A; García-González, L; Yépez-Mulía, L | 1 |
| Feng, K; Li, N; Liu, FJ; Lou, WY; Wen, P; Wu, H; Zhu, DH; Zong, MH | 1 |
| Dong, Y; Feng, S; He, W; Jiang, L; Liang, Z; Tang, S; Wang, R; Xu, P; Yang, L; Zhang, D; Zhang, J; Zhao, T | 1 |
| Abrego, G; Calpena, AC; Clares, B; García, ML; Garduño-Ramírez, ML; Parra, A; Rosselló, A | 1 |
| Akbarzadeh, A; Alizadeh, E; Azizi Jalalian, F; Davaran, S; Gorjikhah, F; Hasanzadeh, A; Panahi, Y; Salehi, R | 1 |
| Behnamghader, A; Mobedi, H; Rahimi, M | 1 |
| Argirò, M; Biondi, M; Crispi, S; Forte, M; Giarra, S; Mayol, L; Mita, DG; Mita, L; Piras, L; Saija, A; Serri, C | 1 |
| Bhandi, MM; Borkar, RM; Gudem, S; Kadari, A; Kolapalli, VR; Kulhari, H; Sistla, R | 1 |
| Chantasart, D; Rakkaew, P; Suksiriworapong, J | 1 |
| Demyanova, E; Kartsova, L; Makeeva, D; Polikarpova, D; Roshchina, E; Vakhitov, T | 1 |
43 other study(ies) available for lactic acid and betadex
| Article | Year |
|---|---|
A stable water-soluble tetramethylbenzidine-2-hydroxypropyl-beta-cyclodextrin inclusion complex and its applications in enzyme assays.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Benzidines; beta-Cyclodextrins; Chromogenic Compounds; Cyclodextrins; Drug Stability; Electrochemistry; Glucose; Glutamic Acid; Horseradish Peroxidase; Hydrogen Peroxide; Hydrogen-Ion Concentration; Lactates; Lactic Acid; Solubility; Spectrophotometry; Water | 1994 |
Encapsulation and release of rhodium(II) citrate and its association complex with hydroxypropyl-beta-cyclodextrin from biodegradable polymer microspheres.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; alpha-Cyclodextrins; Antineoplastic Agents; beta-Cyclodextrins; Cyclodextrins; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rhodium; Solubility | 1999 |
Conformational stability of a model protein (bovine serum albumin) during primary emulsification process of PLGA microspheres synthesis.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Calorimetry, Differential Scanning; Cyclodextrins; Emulsions; Excipients; Lactic Acid; Mannitol; Microspheres; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Protein Conformation; Serum Albumin, Bovine; Sodium Dodecyl Sulfate; Surface-Active Agents | 2003 |
Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Inhalation; Animals; beta-Cyclodextrins; Bronchoalveolar Lavage Fluid; Drug Carriers; Lactic Acid; Lung; Male; Particle Size; Pharmaceutical Solutions; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Porosity; Powders; Rats; Rats, Sprague-Dawley; Trachea; Triptorelin Pamoate | 2004 |
How cyclodextrin incorporation affects the properties of protein-loaded PLGA-based microspheres: the case of insulin/hydroxypropyl-beta-cyclodextrin system.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Cattle; Insulin; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Proteins; Spectroscopy, Fourier Transform Infrared | 2005 |
Local release of dexamethasone from polymer millirods effectively prevents fibrosis after radiofrequency ablation.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Anti-Inflammatory Agents; beta-Cyclodextrins; Biocompatible Materials; Catheter Ablation; Dexamethasone; Drug Delivery Systems; Drug Implants; Fibrosis; Humans; In Vitro Techniques; Lactic Acid; Liver; Liver Neoplasms; Male; Materials Testing; Microscopy, Electron, Scanning; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Sprague-Dawley | 2006 |
Determination of vitamin C and preservatives in beverages by conventional capillary electrophoresis and microchip electrophoresis with capacitively coupled contactless conductivity detection.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Acetates; Ascorbic Acid; Benzoates; beta-Cyclodextrins; Beverages; Cetrimonium; Cetrimonium Compounds; Electric Conductivity; Electrophoresis, Capillary; Electrophoresis, Microchip; Food Additives; Food Preservatives; Hydrogen-Ion Concentration; Lactic Acid; Sorbic Acid | 2005 |
Effect of cyclodextrins on alpha-chymotrypsin stability and loading in PLGA microspheres upon S/O/W encapsulation.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Chymotrypsin; Drug Compounding; Emulsions; Enzyme Stability; Excipients; Lactic Acid; Methylene Chloride; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solvents; Surface Properties; Water | 2006 |
Conjugates of poly(DL-lactic acid) with ethylenediamino or diethylenetriamino bridged bis(beta-cyclodextrin)s and their nanoparticles as protein delivery systems.
Topics: Animals; beta-Cyclodextrins; Cattle; Drug Delivery Systems; Ethylenediamines; Lactic Acid; Nanostructures; Polyesters; Polymers; Serum Albumin, Bovine | 2006 |
Long acting porous microparticle for pulmonary protein delivery.
Topics: Administration, Inhalation; beta-Cyclodextrins; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Stability; Emulsions; Kinetics; Lactic Acid; Microspheres; Oils; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Porosity; Proteins; Serum Albumin, Bovine; Solubility; Sucrose; Surface Properties; Technology, Pharmaceutical; Viscosity; Water | 2007 |
Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; 2-Methoxyestradiol; Angiogenesis Inhibitors; beta-Cyclodextrins; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Implants; Estradiol; Excipients; Injections; Kinetics; Lactic Acid; Lauric Acids; Magnesium; Molecular Weight; Poloxamer; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Solubility; Technology, Pharmaceutical; Water | 2008 |
A convenient preparation of 6-oligo(lactic acid)cyclomaltoheptaose as kinetically degradable derivative for controlled release of amoxicillin.
Topics: Amoxicillin; beta-Cyclodextrins; Chemistry, Pharmaceutical; Delayed-Action Preparations; Dose-Response Relationship, Drug; Hydrolysis; Kinetics; Lactic Acid; Magnetic Resonance Spectroscopy; Mass Spectrometry; Models, Chemical; Solubility; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Ultraviolet Rays | 2008 |
Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Inhalation; Aerosols; Animals; beta-Cyclodextrins; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Hypoglycemic Agents; Insulin; Lactic Acid; Lung; Male; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Rats; Rats, Wistar; Tissue Distribution | 2009 |
Single and multi-layered nanofibers for rapid and controlled drug delivery.
Topics: beta-Cyclodextrins; Delayed-Action Preparations; Electrochemistry; Haloperidol; Lactic Acid; Nanofibers; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol | 2010 |
Synthesis and in vitro release of adriamycin from star-shaped poly(lactide-co-glycolide) nano- and microparticles.
Topics: Antibiotics, Antineoplastic; beta-Cyclodextrins; Calorimetry, Differential Scanning; Caproates; Catalysis; Doxorubicin; Excipients; Lactic Acid; Magnetic Resonance Spectroscopy; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solvents; Tin | 2010 |
Intravesical Toll-like receptor 7 agonist R-837: optimization of its formulation in an orthotopic mouse model of bladder cancer.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adjuvants, Immunologic; Administration, Intravesical; Aminoquinolines; Animals; beta-Cyclodextrins; Chemistry, Pharmaceutical; Cystitis; Cytokines; Disease Models, Animal; Excipients; Female; Imiquimod; Lactic Acid; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Polyethylenes; Polypropylenes; Toll-Like Receptor 7; Urinary Bladder Neoplasms | 2010 |
Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Brain Neoplasms; Camptothecin; Cell Line, Tumor; Drug Carriers; Drug Compounding; Female; Glioma; Lactic Acid; Nanoparticles; Neoplasm Transplantation; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Inbred F344; Surface-Active Agents | 2011 |
Development of polymeric and cyclodextrin nanoparticles for camptothecin delivery.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Camptothecin; Cell Line; Drug Delivery Systems; Humans; Lactic Acid; Mice; Nanoparticles; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2010 |
The effect of HPβCD on Cyclosporine A in-vitro release from PLGA nanoparticles.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Cyclosporine; Lactic Acid; Magnetic Resonance Spectroscopy; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility | 2010 |
PLGA microparticles encapsulating prostaglandin E1-hydroxypropyl-β-cyclodextrin (PGE1-HPβCD) complex for the treatment of pulmonary arterial hypertension (PAH).
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Alprostadil; Animals; Antihypertensive Agents; beta-Cyclodextrins; Cell Line; Cell Survival; Delayed-Action Preparations; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Infusion Pumps; Lactic Acid; Male; Microscopy, Electron, Scanning; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley | 2011 |
Design of curcumin loaded cellulose nanoparticles for prostate cancer.
Topics: Apoptosis; beta-Cyclodextrins; Cell Line, Tumor; Cell Proliferation; Cellulose; Chemistry, Pharmaceutical; Curcumin; Humans; Lactic Acid; Magnetics; Male; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostatic Neoplasms; Tumor Stem Cell Assay | 2012 |
Development and characterization of antimicrobial poly(l-lactic acid) containing trans-2-hexenal trapped in cyclodextrins.
Topics: Aldehydes; Alternaria; Anti-Infective Agents; beta-Cyclodextrins; Botrytis; Colletotrichum; Cyclodextrins; Food Packaging; Food Preservation; Fungi; Lactic Acid; Permeability; Poly I; Polymers; Starch; Tensile Strength | 2012 |
Role of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA-PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Ophthalmic; Analysis of Variance; Animals; beta-Cyclodextrins; Cornea; Cryoprotective Agents; Drug Stability; Epithelium, Corneal; Flurbiprofen; Freeze Drying; Gamma Rays; Lactic Acid; Male; Nanospheres; Particle Size; Polyethylene Glycols; Polyglactin 910; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits | 2012 |
Improved enzyme activity and stability in polymer microspheres by encapsulation of protein nanospheres.
Topics: Acetates; beta-Cyclodextrins; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Enzyme Stability; Freeze Drying; Horseradish Peroxidase; Kinetics; Lactic Acid; Microspheres; Nanospheres; Nanotechnology; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Solvents; Technology, Pharmaceutical | 2012 |
PLA nanoparticles coated with a β-cyclodextrin polymer shell: preparation, characterization and release kinetics of a hydrophobic compound.
Topics: Benzophenones; beta-Cyclodextrins; Calorimetry, Differential Scanning; Hydrophobic and Hydrophilic Interactions; Kinetics; Lactic Acid; Microscopy, Electron, Scanning; Nanoparticles; Polyesters; Polymers | 2012 |
Drug loading of polymeric micelles.
Topics: Anti-Inflammatory Agents; beta-Cyclodextrins; Dexamethasone; Drug Carriers; Excipients; Freeze Drying; Lactic Acid; Micelles; Polyesters; Polyethylene Glycols; Polymers; Polyvinyls | 2013 |
HP-β-CD-PLGA nanoparticles improve the penetration and bioavailability of puerarin and enhance the therapeutic effects on brain ischemia-reperfusion injury in rats.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Biological Availability; Blood-Brain Barrier; Brain Ischemia; Chromatography, High Pressure Liquid; Drug Carriers; Gelatin; Isoflavones; Lactic Acid; Male; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Reperfusion Injury; Solubility; Time Factors; Tissue Distribution; Tomography, X-Ray Computed; Vasodilator Agents; Viscosity | 2013 |
Effect of stabilizers on bioactivity of peptide-24 in PLGA microspheres.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Alkaline Phosphatase; Animals; beta-Cyclodextrins; Lactic Acid; Mesenchymal Stem Cells; Microspheres; Oligopeptides; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Protein Stability; Rabbits; Serum Albumin, Bovine; Surface Properties | 2013 |
Flurbiprofen PLGA-PEG nanospheres: role of hydroxy-β-cyclodextrin on ex vivo human skin permeation and in vivo topical anti-inflammatory efficacy.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adult; Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Female; Flurbiprofen; Humans; Inflammation; Lactic Acid; Nanospheres; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Skin; Skin Absorption | 2013 |
NanoXCT: a novel technique to probe the internal architecture of pharmaceutical particles.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Inhalation; beta-Cyclodextrins; Drug Carriers; Lactic Acid; Lipids; Mannitol; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Serum Albumin, Bovine; Signal-To-Noise Ratio; Technology, Pharmaceutical; Tomography, X-Ray Computed | 2014 |
Polymeric supra-amphiphiles based on terminal group electrostatic interactions: fabrication of micelles with modifiable surfaces.
Topics: Antineoplastic Agents; beta-Cyclodextrins; Biological Transport; Cell Survival; Doxorubicin; Drug Carriers; Drug Compounding; Drug Liberation; HeLa Cells; Humans; Lactic Acid; Micelles; Molecular Structure; Polyesters; Polymers; Solutions; Static Electricity; Surface Properties; Surface-Active Agents; Water | 2014 |
Unimolecular micelles of amphiphilic cyclodextrin-core star-like block copolymers for anticancer drug delivery.
Topics: Antineoplastic Agents; beta-Cyclodextrins; Doxorubicin; Drug Delivery Systems; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Micelles; Polyesters; Polyethylene Glycols; Polymers | 2015 |
Improved thermal stability of polylactic acid (PLA) composite film via PLA-β-cyclodextrin-inclusion complex systems.
Topics: beta-Cyclodextrins; Calorimetry, Differential Scanning; Lactic Acid; Nanocomposites; Polyesters; Polymers; Surface Properties; Temperature; Tensile Strength; Thermodynamics; Thermogravimetry | 2015 |
Effect of β-cyclodextrin on the internalization of nanoparticles into intestine epithelial cells.
Topics: beta-Cyclodextrins; Biological Transport; Caco-2 Cells; Cell Nucleus; Cell Survival; Cytoplasm; Epithelial Cells; Humans; Intestines; Lactic Acid; Mucins; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2016 |
Fabrication of electrospun polylactic acid nanofilm incorporating cinnamon essential oil/β-cyclodextrin inclusion complex for antimicrobial packaging.
Topics: Anti-Infective Agents; beta-Cyclodextrins; Cinnamomum zeylanicum; Escherichia coli; Food Packaging; Lactic Acid; Microbial Sensitivity Tests; Nanofibers; Oils, Volatile; Polyesters; Polymers; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus | 2016 |
Nanomaterial-dependent immunoregulation of dendritic cells and its effects on biological activities of contraceptive nanovaccines.
Topics: Animals; beta-Cyclodextrins; Contraceptive Agents; Cytokines; Dendritic Cells; Drug Liberation; Female; Fertility; Hydrogen-Ion Concentration; Hydrolysis; Immunoglobulin G; Lactic Acid; Male; Mice, Inbred C57BL; Nanoparticles; Peptides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Receptors, FSH; Sperm Count; Sperm Motility; T-Lymphocytes; Vaccines | 2016 |
Ex vivo permeation of carprofen from nanoparticles: A comprehensive study through human, porcine and bovine skin as anti-inflammatory agent.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Topical; Animals; Anti-Inflammatory Agents; beta-Cyclodextrins; Carbazoles; Cattle; Edema; Female; Freeze Drying; Humans; In Vitro Techniques; Lactic Acid; Male; Mice; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Skin; Swine; Tetradecanoylphorbol Acetate | 2016 |
Preparation and characterization of PLGA-β-CD polymeric nanoparticles containing methotrexate and evaluation of their effects on T47D cell line.
Topics: Antineoplastic Agents; beta-Cyclodextrins; Biological Transport; Cell Survival; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Liberation; Female; Humans; Kinetics; Lactic Acid; MCF-7 Cells; Methotrexate; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2017 |
In situ-forming PLGA implants loaded with leuprolide acetate/β-cyclodextrin complexes: mathematical modelling and degradation.
Topics: beta-Cyclodextrins; Drug Implants; Lactic Acid; Leuprolide; Models, Chemical; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2016 |
Nano-precipitated curcumin loaded particles: effect of carrier size and drug complexation with (2-hydroxypropyl)-β-cyclodextrin on their biological performances.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Cell Line, Tumor; Cell Survival; Cells, Cultured; Chemical Precipitation; Curcumin; Drug Carriers; Drug Liberation; Drug Stability; Humans; Lactic Acid; Nanoparticles; Particle Size; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2017 |
Enhanced oral bioavailability and anticancer efficacy of fisetin by encapsulating as inclusion complex with HPβCD in polymeric nanoparticles.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; beta-Cyclodextrins; Biological Availability; Breast Neoplasms; Cell Line, Tumor; Female; Flavonoids; Flavonols; Humans; Lactic Acid; MCF-7 Cells; Mice; Mice, Inbred C57BL; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Reactive Oxygen Species; Solubility | 2017 |
β-Cyclodextrin-based ternary complexes of haloperidol and organic acids: the effect of organic acids on the drug solubility enhancement.
Topics: Antipsychotic Agents; beta-Cyclodextrins; Drug Carriers; Drug Compounding; Haloperidol; Lactic Acid; Solubility; Succinic Acid; Tartrates; Water | 2018 |
Determination of native amino acids and lactic acid inLactobacillus helveticusculture media by capillary electrophoresis using Cu
Topics: Amino Acids; beta-Cyclodextrins; Copper; Culture Media; Electrophoresis, Capillary; Lactic Acid; Lactobacillus helveticus | 2020 |